ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - etoricoxib - טבליות מצופות פילם - etoricoxib 90 mg - etoricoxib - etoricoxib - arcoxia 90 mg tablets are indicated for the symptomatic relief of rheumatoid arthritis (ra) and ankylosing spondylitis.for the short-term treatment of moderate pain associated with dental surgery.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - etoricoxib - טבליות מצופות פילם - etoricoxib 120 mg - etoricoxib - etoricoxib - arcoxia 120 mg tablets are indicated for the symptomatic relief of the pain and signs of inflammation associated with acute gouty arthritis.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - etoricoxib - טבליות מצופות פילם - etoricoxib 30 mg - etoricoxib - etoricoxib - arcoxia tablets are indicated for the symptomatic relief of osteoarthritis (oa).

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - rizatriptan as benzoate - טבליה - rizatriptan as benzoate 10 mg - rizatriptan - rizatriptan - rizalt is indicated for the acute treatment of migraine attacks with or without aura in adults.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - rizatriptan as benzoate - טבליות מתמוססות בפה - rizatriptan as benzoate 10 mg - rizatriptan - rizatriptan - rizalt is indicated for the acute treatment of migraine attacks with or without aura in adults.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - carbidopa as monohydrate; levodopa - טבליות בשחרור מבוקר - levodopa 200 mg; carbidopa as monohydrate 50 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - idiopathic parkinson's disease. postencephalitic parkinsonism. symptomatic parkinsonism. to reduce "off" time in patients previously treated with levodopa/decarboxylase inhibitor preparations, or with levodopa alone, who have had motor fluctuations characterized by end-of-dose deterioration ("wearing-off" phenomenon), peak dose dyskinesias, akinesia, or similar evidence of short-duration motor disturbances.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - טבליות לעיסות - montelukast as sodium 5 mg - montelukast - montelukast - singulair 5 mg is indicated in adult and pediatric patients 6 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singular is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and padiatric patients 2 years of age and older.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - טבליה - montelukast as sodium 10 mg - montelukast - montelukast - singulair 10 mg is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singular is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and padiatric patients 2 years of age and older.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - טבליות לעיסות - montelukast as sodium 4 mg - montelukast - montelukast - singulair is indicated in pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction.singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled carticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singular is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and padiatric patients 2 years of age and older.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - desloratadine - טבליה - desloratadine 5 mg - desloratadine - desloratadine - for the relief of symptoms associated with : - allergic rhinitis - urticaria .